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Ethnic populations representing areas throughout California were compared 
regarding cognitive ability, socioeconomic position, and mortality. Cognition and 
socioeconomic position were inversely correlated with mortality. The single 
nucleotide polymorphism rs8191992 in the M2 muscarinic receptor gene (CHRM2) 
was previously linked to IQ and modulation of vagal tone. The CHRM2 vagal 
vigour hypothesis posits that variation at rs8191992 alters the binding site for a 
brain-expressed microRNA (hsa-mir-383) thereby changing expression of brain 
M2 muscarinic receptors to cause pleiotropic effects on cognition and vagus nerve 
signalling which then affects health via the vagal cholinergic anti-inflammatory 
pathway. This may help explain ethnic health differences, including the Hispanic 
Health Paradox, since ethnic differences in rs8191992 allele frequencies 
correspond to ethnic differences in systemic inflammation and mortality. The 
rs8191992 A-allele may contribute to the clustering of low IQ and low vagal tone 
with higher substance abuse, externalizing psychopathology, depression, systemic 
inflammation, metabolic syndrome, and cardiovascular disease. 
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The associations of socioeconomic position (SEP) and ethnicity with differences in 
health and mortality have long been a focus of research in sociology and epidemiology1, 
2. In addition to being linked to health and mortality, SEP and ethnicity show substantial 
associations with IQ3-5. With the advent of cognitive epidemiology, growing attention 
has been directed toward studies of the links between IQ and health6-9. An essay 
introducing the new field of cognitive epidemiology listed four items as high IQ-
associated factors that might serve as links to better health9:  
1) Higher education and SEP leading to healthier home and work environments.  
2) Healthier behaviours such as diet, exercise and smoking habits.  
3) Fewer injuries and illnesses sustained during youth.  
4) A more well-wired body with higher system integrity.  
The fourth item, with its connotation of innate biological differences in disease 
susceptibility, is somewhat akin to the genetic hypothesis presented here, i.e. that a gene 
might exert pleiotropic effects on both cognition and health-related physiology.  
IQ is strongly correlated with academic achievement test performance and IQ is 
moderately correlated with SEP measures such as educational attainment, occupational 
status, and income3, 10, 11, thus it is often difficult to disentangle IQ-effects from SEP-
effects. Therefore a gene allele that modulates IQ might also tend to correlate with SEP, 
and if the same gene allele also exerts pleiotropic effects on a physiological pathway 
that affects disease susceptibility, then the resulting phenotype could manifest as 
covariation in IQ, SEP, and health. A study of the mortality of all persons who were 
born in Denmark from 1924-1947 and who were adopted at young ages, found that the 
adoptees’ adult mortality rates correlated inversely with the SEPs of their biological 
fathers but no correlation was seen with the SEPs of their adoptive fathers12. These 
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results suggest the genetic transmission of some factor (e.g. a gene allele that modulates 
both IQ and health) that correlates with higher parental SEP and that is also linked to 
lower mortality in the biological offspring. This in fact is the essence of the hypothesis 
presented here, the CHRM2 vagal vigour hypothesis, which posits a genetic linkage 
between ethnicity, IQ, SEP and health. This hypothesis will probably prove 
controversial because of the Nature-Nurture controversy. The Nature-Nurture debate 
involves a conflict between two schools of thought regarding the causes of ethnic and 
social class variations in mental traits (Supplementary Table 1). The Galtonians 
(Hereditarians) see ethnic genetic differences as a major determinative factor, while the 
Boasians (Environmentalists) reject the involvement of ethnic genetic differences and 
instead see the persistence of ethnic disparities in political and economic power and 
deep cultural differences as the salient issues. Galtonians tend to see gene-based IQ 
differences as a proximate cause for differences in educational achievement, SEP, and 
culture. Boasians tend to see IQ differences as a consequence of pre-existing differences 
in culture, educational achievement, and SEP. The CHRM2 vagal vigour hypothesis 
reflects the Galtonian perspective but it is hoped that this hypothesis will provoke 
critical discussion and stimulate further research toward understanding the nature of 
associations between ethnicity, IQ, SEP, and health. 
 
Standardized mathematics achievement test scores as an index of cognitive ability 
Academic achievement test scores, particularly mathematics scores, are highly 
correlated with general cognitive ability and the correlation is largely genetic3, 10, 11; thus 
these widely available test scores can serve as a useful resource for gauging population 
IQ levels13. In the USA, as a result of the 2001 No Child Left Behind federal education 
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initiative, most states have administered academic achievement tests (“Standards 
Tests”) to nearly all public school students. The 7th Grade (~13 year old students) 
California Standards Test (CST) mathematics scores from throughout California were 
collated and converted to standard score format (the IQ-metric with 15 points = 1 SD) 
with 100 representing the average of the statewide White population. The statewide 
CST Mathematics scores (Supplementary Fig. 1) show substantial differences in the 
average IQs of the various ethnic populations ranging from African Americans at ~85 to 
East Asians (Japanese, Koreans, and Chinese) at ~111. For further analyses, the 
cognitive ability scores of the various Asian subgroups (including Filipinos but not 
Pacific Islanders) were aggregated to produce a total Asian group that corresponds with 
the available census and mortality data. The scores from each of four years (2003-2006) 
were averaged to estimate the mean IQs of the various ethnic populations 
(Supplementary Fig. 2); and the resulting group IQ scores (Black 85.2, Hispanic 87.7, 
American Indian 90.6, White 100.0, and Asian 104.6) were found to be similar to 
previously reported values4, 5. 
 
Cognitive epidemiology of ethnicity, SEP, and mortality in California 
Using a geographic area-based measures approach, the state of California was divided 
into 220 area zones corresponding to low population counties, individual school 
districts, the seven learning districts which comprise the Los Angeles school district, 
and aggregates of adjoining smaller school districts. Using CST 7th Grade 2003-2006 
Mathematics scores, average IQ estimates were determined for the populations residing 
within each zone and plotted against an index of SEP that reflects the prevalence of 
college graduates and high household incomes within the total population of each zone 
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(Fig. 1a) or within the ethnic populations of each zone (Fig 1d). These data show that 
variations in the level of cognitive ability between different area populations correlate 
strongly (r = .86) with variations in their SEP. There is a strong inverse correlation 
between the SEPs of the various regional populations and their mortality at ages 55 to 
64 (Fig. 1b). In the USA the mortality of Hispanics is lower than expected in view of 
their low SEP, this is known as the Hispanic Health Paradox14. When the data are 
disaggregated into ethnic groups the Hispanic populations show lower mortality than 
some White populations of higher SEP (Fig. 1e), thus these data exhibit the classic 
Hispanic Health Paradox (low mortality associated with low SEP).  Cognitive ability 
also shows a strong inverse correlation with mortality in the total population data (Fig. 
1c). With the ethnic population data, a new manifestation (low mortality associated with 
low IQ) of the Hispanic Health Paradox is evident in which Hispanic populations tend 
to show lower mortality than some White populations of higher average cognitive 
ability (Fig. 1f). In the USA, persons of full or partial Native American ancestry are 
usually designated as “American Indians” if their ancestors lived north of the USA-
Mexico border but they are usually designated as “Hispanics” if their ancestors lived 
south of the border; thus genetic similarity between Hispanics and Native Americans is 
expected and has been documented15. The current data show similarity between 
Hispanics and American Indians in regard to IQ, SEP and mortality suggesting that a 
phenomenon similar to the Hispanic Health Paradox also involves the American Indian 
population.  
To investigate with more power the pattern of the relationships between IQ, 
ethnicity, and mortality, area populations of similar average IQ and of the same 
ethnicity from different zones from throughout the state were collated and aggregated 
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into larger groups. The Asian, Hispanic and Black populations were each binned into 
tertile groups, while the much larger White population was binned into hexile groups, 
and the less numerous American Indian population was collated into one group. For 
clarification, the relationship between ethnicity and IQ and total natural cause mortality 
(at ages 55 to 64) is displayed in both unbinned (Fig. 1f) and binned (Fig. 1g) formats. 
Also shown are ethnicity and IQ in relation to mortality due to cardiovascular diseases 
(Fig. 1h) and cancers (Fig. 1i). To assess the validity of these IQ versus mortality plots 
of ethnic population data from California, a similar analysis was performed on nation-
wide ethnic population cognitive test score (2000, 2003, 2005, & 2007 NAEP National 
8th Grade Mathematics) and mortality (1997-2005 Center for Disease Control National 
Vital Statistics System) data; the nationwide ethnic group data points (larger unfilled 
symbols) align moderately well with the midrange points from the California ethnic 
populations (Fig. 1g,h,i); thus confirming the validity of these analyses. The proportions 
of mortality which are due to various specific diseases and external causes are 
illustrated for the collated IQ/ethnic populations for both men and women 
(Supplementary Figures 3 & 4); these data suggest that the association between IQ and 
mortality and the Hispanic Health Paradox effect is rather similar in both sexes. The 
relationship of ethnicity and IQ to mortality at various ages due to external causes 
(chiefly accidents, homicide and suicide) is shown (Supplementary Fig. 5). Suicides are 
seen to be particularly prevalent in lower IQ Whites and homicide deaths are extremely 
prevalent in younger lower IQ Blacks. The relationships of ethnicity and IQ to mortality 
at various ages due to non-cancer natural causes (Supplementary Fig. 6) and cancers 
(Supplementary Fig. 7) are also shown. The inverse relationship between IQ and 
mortality is seen to be most evident in cardiovascular disease, chronic lung disease 
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(asthma/COPD/emphysema), and in some cancers involving the aerodigestive tract 
(head and neck, lung, oesophagus, pancreas, and colon) and the urinary tract (kidneys 
and bladder). No obvious IQ effect is evident in rates of deaths due to melanoma or 
sarcoma or from tumours of the stomach, biliary tract, breast, ovaries, uterus, prostate, 
or brain. 
 
 
The CHRM2 vagal vigour hypothesis 
The concept of a mind-body connection mediated by the vagus nerve has been studied 
since the time of Claude Bernard but in the past decade there has been growing interest 
in the vagal mind-body connection with Tracey’s discovery of the vagal cholinergic 
anti-inflammatory pathway16 and Thayer’s development of the neurovisceral integration 
model which focuses on interconnections between emotive and cognitive brain 
functions, vagal tone (frequency of vagal signalling), and psychological and physical 
health17. Vagal tone is usually measured by one of three methods: heart rate variability 
(HRV), heart rate recovery (HRR), or respiratory sinus arrhythmia (RSA). The CHRM2 
vagal vigour hypothesis (Fig. 2) incorporates prior concepts such as the vagal 
cholinergic anti-inflammatory pathway16 and some aspects of the neurovisceral 
integration model17, but importantly this new hypothesis includes a specific molecular 
genetic connection between cognition and vagal tone by postulating that the derived T-
allele of the CHRM2 3-prime untranslated region (3’UTR) single nucleotide 
polymorphism (SNP) rs8191992 exerts pleiotropic effects to increase both cognitive 
functioning (which then indirectly results in increased SEP) and vagal nerve signalling 
(which results in better health via the cholinergic anti-inflammatory pathway). This 
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CHRM2 vagal vigour hypothesis also raises the suggestion that ethnic variation in 
rs8191992 allele frequency is a cause for ethnic variation in health and mortality. Three 
research groups have reported that variations in CHRM2 SNPs are linked to variation in 
IQ, in particular the T-alleles of SNPs rs324650 and rs8191992 have been associated 
with increased IQ18-20 (information about these three studies, and about one negative 
study, is presented in Supplementary Table 2). The T-allele of rs8191992 has also been 
associated with increased vagal tone21, 22. In regard to six SNPs (rs324650, rs8191992, 
rs6962027, rs6967953, rs1378650, rs17506824) located in the 3-prime region of the 
CHRM2 gene (Fig. 2a), in Asians the most common linkage haplotype is TTTTTT, in 
Blacks AAACCC is common, whereas Whites have a mixture of haplotypes (Fig. 2b 
and Supplementary Fig 8). Based on the available data, it appears that Native 
Americans resemble Asians in their allele frequencies within this genomic region and 
that Hispanics are intermediate between Whites and Asians (Fig. 2b).  
In addition to IQ18-20  and vagal tone21, 22, SNP variations in the CHRM2 gene 
have been associated with depression, and disinhibitory psychological disorders 
including alcoholism, drug abuse, and externalizing psychopathology23-25; this suggests 
that at least one of the CHRM2 SNPs must be a functional SNP. Since no SNP is 
present within the protein coding portion of the CHRM2 gene, the functional SNP must 
be exerting its effect by altering CHRM2 gene expression. It is difficult to envision a 
specific mechanism whereby SNPs present in the middle of a large intron (rs324650) or 
within downstream nontranscribed DNA (rs6962027, rs6967953, rs1378650, 
rs17506824) could strongly alter gene expression; however a specific mechanism is 
evident for the 3’UTR SNP rs8191992. This is because the rs8191992 T-allele improves 
a seed binding site for the brain-expressed microRNA hsa-mir-383 (Fig. 2c). In the 
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brain, M2 muscarinic receptors are primarily inhibitory presynaptic receptors, thus a 
decrease in their expression is expected to increase neurotransmitter release and 
synaptic transmission. Centrally acting M2 muscarinic antagonist drugs have been 
found to increase cognitive functioning in rodents and primates26, and to increase vagal 
tone in rats27.  By increasing the binding of hsa-mir-383, the rs8191992 T-allele would 
be expected to decrease expression of brain M2 muscarinic receptors and thereby cause 
increased cognitive functioning and increased vagal tone (Fig. 2d).  
 
Ethnicity, CHRM2 allele frequency, systemic inflammation, and mortality 
The CHRM2 vagal vigour hypothesis postulates that the lower cardiovascular and 
cancer mortality rates (Fig. 1h,i) seen in Hispanics, American Indians, and Asians are 
due in part to their higher frequencies of the rs8191992 T-allele (compared to Whites) 
and that the higher cardiovascular and cancer mortality in Blacks is due in part to their 
lower frequency of the rs8191992 T-allele. Two recent studies of ethnic differences in 
levels of systemic inflammation found that Asians tend to have lower levels and Blacks 
tend to have higher levels28, 29, these data (median C-reactive protein levels in middle 
aged women) are displayed here (Fig. 2f) for comparison with ethnic variations in 
rs8191992 A-allele frequencies (Fig. 2e) and late middle age natural cause mortality 
(Fig. 2g).  When viewed from the perspective of the CHRM2 vagal vigour hypothesis 
the lower mortality of Hispanics is not paradoxical and in this respect the Hispanic 
Health Paradox can be resolved. However then the lower IQs (Fig. 1 and Supplementary 
Fig. 1 & 2) and the higher rates of alcohol-related diseases (Supplementary Fig. 6) seen 
in Hispanics and American Indians remain as discrepancies within the CHRM2 vagal 
vigour model since these populations appear to have high levels of the T-allele (Fig. 
10 
2a,b) even though prior studies have associated the T-allele with higher IQ and lower 
alcoholism18, 20, 23, 24.   
 
 
Discussion 
The rs8191992 A-allele was associated with depression30, lower IQ18, 20, and lower 
vagal tone21, 22, this in combination with the vagal cholinergic anti-inflammatory 
pathway16 and the connection of inflammation with atherosclerosis31, may explain why 
depression is often associated with low IQ, low vagal tone, and increased systemic 
inflammation and cardiovascular disease32-36. Variation in the CHRM2 3’UTR SNP 
rs8191992 has also been associated with alcoholism/drug abuse23, 24, and externalizing 
psychopathology25. Thus in a more general sense, the CHRM2 vagal vigour hypothesis 
postulates that the presence of the A-allele of rs8191992 may underlie the 
epidemiological clustering of low IQ (and subsequent low SEP) and low vagal tone with 
higher substance abuse, externalizing psychopathology, depression, systemic 
inflammation, metabolic syndrome, and cardiovascular disease. Consistent with this 
model, low vagal tone has been associated with lower indices of cognition (reaction 
times, executive functions, working memory, and IQ)17, 37, 38 and lower SEP39. Lower 
vagal tone has also been associated with increased all cause mortality40, cardiovascular 
disease41, type-2 diabetes/metabolic syndrome42, major depression33,35, alcoholism43, 
and externalizing psychopathology44. Furthermore, because low vagal tone has been 
linked to higher levels of systemic inflammation16, 45-47 and because inflammation has 
been linked to the development of major aging-related diseases such as 
atherosclerosis31, type-2 diabetes/metabolic syndrome48, and cancer49, it is plausible that 
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vagal nerve signalling could be an important general regulator of health and longevity. 
Consistent with this notion, a widely used experimental anti-aging protocol–caloric 
restriction in rats–was found to be associated with activation of vagal tone50. The 
CHRM2 vagal vigour hypothesis raises the possibility that molecules that inhibit brain 
M2 muscarinic receptors might increase cognitive ability, vagal tone, and health and 
longevity, particularly in persons who are homozygous for the rs8191992 A-allele.  
To summarize, this CHRM2 vagal vigour model posits that the derived T-allele of 
the CHRM2 3’UTR SNP rs8191992 improves a seed binding site for the brain-
expressed microRNA hsa-mir-383 thus decreasing brain expression of M2 muscarinic 
receptors which leads to increased cognition, increased vagal tone, and better health. 
This may help to explain some previously puzzling associations of cognitive ability and 
SEP with ethnicity, vagal tone, systemic inflammation, and health. The mortality of 
Hispanics is lower than expected in view of their low SEP, this is known as the 
Hispanic Health Paradox14. It appears that Hispanics, due to Native American ancestry, 
have a low frequency (0.33) of the low vagal tone-associated A-allele of rs8191992; this 
may account for the low Hispanic mortality rates. The CHRM2 vagal vigour hypothesis 
offers an explanation for why the rs8191992 A-allele frequencies in Blacks (0.86), 
Whites (0.56), and East Asians (0.12) correspond with the respective ethnic differences 
in systemic inflammation28, 29 and mortality2(Fig. 2d,e,f,g). Lastly, by postulating a 
common shared link to the presence of the rs8191992 A-allele, the CHRM2 vagal 
vigour model provides an explanation for why low IQ, low SEP, low vagal tone, 
depression, substance abuse, externalizing psychopathology, systemic inflammation, 
type 2 diabetes/metabolic syndrome, and cardiovascular disease often cluster together. 
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Figure Legends: 
 
Figure 1 Cognitive epidemiology of ethnic populations comparing 
IQ, SEP, and mortality (age 55-64, yearly deaths per 100,000).  a, 
Scatter-plot of IQ versus SEP of each area zone’s total population. 
b, SEP versus mortality (♦ all cause, ♦ natural cause) of total 
population. c, IQ versus mortality (♦ all cause, ♦ natural cause) of 
total population. d, IQ versus SEP of each area zone’s ethnic 
populations. e, SEP versus natural cause mortality of ethnic 
populations. f, IQ versus natural cause mortality of ethnic 
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populations. IQ (binned ethnic population data) compared with: g, 
natural cause mortality; h, cardiovascular disease mortality; and i, 
cancer mortality. d-i, ■ Black, ■ Hispanic, ■ American Indian, ■ 
White, ■ Asian. g,h,i, Error bars are 95% confidence intervals. 
Unfilled symbols are nationwide USA data. SEP estimates were 
from US Census 2000 data with SEP = (Pedu + Pinc) · 50 where Pedu 
= fraction of adults age ≥ 25 with bachelor’s degree or higher and 
Pinc = fraction of adults age 35-64 with annual household income of 
≥ $75,000. IQ estimates were derived using the Excel NORMINV 
function with IQgroup = NORMINV(Pgroup,0,15) - 
NORMINV(PWhite,0,15) + 100 where Pgroup = fraction of group and  
Pwhite = fraction of statewide Whites who score proficient or above 
on California CST 7th grade maths (years 2003-2006; 
//star.cde.ca.gov ). California mortality data (all deaths from years 
1999-2005) were obtained from the CA Dept. of Public Health. SEP 
and mortality data, which were localized to ZipCode areas, were 
linked and aggregated to correspond to the area zones of the CST 
maths-derived IQ data. Larger empty symbols in g-i represent 
national NAEP 8th grade maths-derived IQ (years 2000, 2003, 
2005, & 2007; //www.nces.ed.gov/nationsreportcard ) and 
nationwide mortality (years 1997-2005 CDC NVSS database 
//www.cdc.gov/nchs/hdi.htm). 
 
 
19 
Figure 2 The CHRM2 vagal vigour hypothesis. a, Location of six 
SNPs in the 3-prime region of the CHRM2 gene.  b,  Ethnic allele 
frequencies at these six CHRM2 SNPs. c,  Seed binding site 
interaction of microRNA hsa-miR-383 with the 3’UTR region of the 
CHRM2 mRNA. d,  Schematic summary of the CHRM2 vagal 
vigour hypothesis. e,  CHRM2 SNP rs8191992 A-allele frequencies 
of Hispanic, Black, White, and Asian populations. f,  Systemic 
inflammation in ethnic populations, median serum C-reactive 
protein levels in middle aged women (█ ~55 years old28, █ ~46 
years old29). g,  Natural cause mortality (age 55-64, yearly deaths 
per 100,000) in USA Nationwide ethnic populations. Ethnic group 
SNP allele frequencies for Whites, Blacks, and Asians are from the 
HapMap and Perlegen data and for Hispanics (Mexicans) are from 
HapMap data. The data set containing SNP allele frequencies for 
Indians (Native American groups Maya, Nahua, Quechua, and 
Aymara from Mexico, Bolivia, and Peru15) was obtained from 
Xianyun Mao and Mark Shriver. The CRP data are from Albert et 
al.28 and Kelley-Hedgepeth et al.29 The nationwide mortality data 
are from years 1997-2005 (CDC NVSS database 
//www.cdc.gov/nchs/hdi.htm). 
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Supplementary Figure 1  Statewide scores from the 2006 7th Grade Mathematics California 
Standards Test (CST). Shown are the number tested from each ethnic group and the 
standard score (IQ metric) derived from the fractions Proficient or Advanced by using the 
Excel NORMINV function with IQgroup = NORMINV(Pgroup,0,15) - NORMINV(PWhite,0,15) + 100 
where Pgroup = fraction of group and Pwhite = fraction of statewide Whites who score proficient                
or above on the California CST 7th grade mathematics test. (data source 
http://star.cde.ca.gov/star2006/Viewreport.asp). 
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Supplementary Figure 2  Statewide scores from 2003-2006 on the 7th Grade Mathematics 
California Standards Test (CST). Shown are the number tested each year from each ethnic 
group and the standard score (IQ metric) derived from the fractions Proficient or Advanced by 
using the Excel NORMINV function with IQgroup = NORMINV(Pgroup,0,15) - 
NORMINV(PWhite 0 15) + 100 where Pgroup = fraction of group and Pwhite = fraction of, ,               
statewide Whites who score proficient or above on the California CST 7th grade mathematics 
test. The final estimate is the average of the values for each of the four years. 
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Homicide (X85-Y09,Y87.1): 
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Suicide (X60-X84,Y87.0): 
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Supplementary Figure 5  Cognitive epidemiology of mortality (yearly deaths per 100,000) in California due to external causes at various 
ages in relation to IQ and ethnicity. ■ Black, ■ Hispanic, ■ American Indian, ■ White, ■ Asian. Error bars are 95% confidence intervals. 
(ICD10 Group Cause of Death Codes). 
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Cerebrovascular Disease (I60 I69): -
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Hypertension (I10-I13): 
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Other Atherosclerosis and Vascular Disease (I26,I70-I78,I80-I99): 
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Diabetes Mellitus (E10 E14):  -
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Chronic Lower Respiratory Diseases (J40-J47): 
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Alcohol Related Diseases (F10,K70,K74,K85,K86.1-K86.2): 
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Supplementary Figure 6  Cognitive epidemiology of mortality (yearly deaths per 100,000) in California due to noncancer 
natural causes at various ages in relation to IQ and ethnicity. ■ Black, ■ Hispanic, ■ American Indian, ■ White, ■ Asian. 
Error bars are 95% confidence intervals. (ICD10 Group Cause of Death Codes). 
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Colorectal Cancer (C18-C20): 
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Head & Neck Cancer (C00-C14,C30-C32): 
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Stomach Cancer (C16): 
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Liver Cancer (C22.0,C22.2-C22.9): 
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Biliary Cancer (C22.1,C23-C24): 
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Bladder Cancer (C67):
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Renal Cancer (C64-C65): 
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Prostate Cancer (C61): 
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Uterine Cancer (C54,C55): 
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Brain & CNS Neoplasm (C70 C72):    -
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Lymphoma & Leukemia (C81-C96): 
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Supplementary Figure 7  Cognitive epidemiology of mortality (yearly deaths per 100,000) in California due to 
cancer at various ages in relation to IQ and ethnicity. ■ Black, ■ Hispanic, ■ American Indian, ■ White, ■ Asian.
Error bars are 95% confidence intervals. (ICD10 Group Cause of Death Codes). 
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Supplementary Figure 8  CHRM2 gene Linkage 
Disequilibrium (LD) plots and haplotype frequencies of 
ethnic groups. a, Asians (Japanese and Chinese). b,
Whites. c, Blacks (Yoruba). Data are from the HapMap 
(http://www.hapmap.org/) and were processed using the 
HaploView program.
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IQ-increaser allele 
 
Study 
 
N 
 
rs324650
 
rs8191992
Δ IQ  
(TT versus AA 
 
Cohort 
 genotype) 
 
Comings et 
al. 2003* 
 
828 
 
– 
 
T* 
 
+4.1 (FSIQ) 
 
Minnesota Twin & Family Study 
 
191 
 
T 
 
– 
 
+8.2 (FSIQ) 
 
Netherlands Twin Registry 
(Family based comparison)
 
Gosso et 
al 2006 -  .  
 
625 
 
T 
 
– 
 
+3.4 (FSIQ) 
 
Netherlands Twin Registry 
(Population-based comparison) 
 
Dick et al. 
2007* 
 
2158 
 
– 
 
T* 
 
+4.9 (PIQ) 
 
Collaborative Study on the 
Genetics of Alcoholism (COGA)
 
Harris et al. 
2007 
 
437 
 
– 
 
No effect 
found 
 
No effect found 
 
Lothian Birth Cohort of 1921 
 
* IMPORTANT NOTE: With regard to the studies by Comings et al. 2003 and Dick et al. 2007, the published 
reports are ambiguous and confusing as per how their reported alleles of rs8191992 correspond with the SNP 
d t b d i t d A d T ll l f 8191992 Thi l ifi d b l i ti f D ida a ase- es gna e   an   a e es o  rs . s was c ar e  y persona  commun ca ons rom av  
Comings (their “allele 1” = dbSNP A allele and their “allele 2” = dbSNP T allele) and from Danielle Dick (because 
a reverse primer was used in their pyrosequencing assay, their “A allele” = dbSNP T allele and their “T allele” = 
dbSNP A allele). Here the dbSNP allele designations are shown. 
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